NO132101B - - Google Patents

Download PDF

Info

Publication number
NO132101B
NO132101B NO4350/68A NO435068A NO132101B NO 132101 B NO132101 B NO 132101B NO 4350/68 A NO4350/68 A NO 4350/68A NO 435068 A NO435068 A NO 435068A NO 132101 B NO132101 B NO 132101B
Authority
NO
Norway
Prior art keywords
methyl
bromo
hydroxy
compound
acid
Prior art date
Application number
NO4350/68A
Other languages
English (en)
Norwegian (no)
Other versions
NO132101C (fr
Inventor
M R Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO132101B publication Critical patent/NO132101B/no
Publication of NO132101C publication Critical patent/NO132101C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • G—PHYSICS
    • G11—INFORMATION STORAGE
    • G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B33/00—Constructional parts, details or accessories not provided for in the other groups of this subclass
    • G11B33/02—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
    • G11B33/04—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon modified to store record carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO4350/68A 1967-11-03 1968-11-01 NO132101C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68030867A 1967-11-03 1967-11-03

Publications (2)

Publication Number Publication Date
NO132101B true NO132101B (fr) 1975-06-09
NO132101C NO132101C (fr) 1975-09-17

Family

ID=24730576

Family Applications (1)

Application Number Title Priority Date Filing Date
NO4350/68A NO132101C (fr) 1967-11-03 1968-11-01

Country Status (14)

Country Link
AT (2) AT297236B (fr)
BE (1) BE723189A (fr)
BR (1) BR6803654D0 (fr)
CH (1) CH505855A (fr)
DK (1) DK131576C (fr)
ES (1) ES359842A1 (fr)
FI (1) FI48098C (fr)
FR (2) FR1605466A (fr)
GB (1) GB1247022A (fr)
IE (1) IE33567B1 (fr)
IL (1) IL30879A (fr)
NL (1) NL6815623A (fr)
NO (1) NO132101C (fr)
SE (1) SE352360B (fr)

Also Published As

Publication number Publication date
DE1805857A1 (de) 1969-06-26
FR8435M (fr) 1971-07-15
FR1605466A (fr) 1976-05-14
NO132101C (fr) 1975-09-17
DE1805857B2 (de) 1977-06-23
NL6815623A (fr) 1969-05-06
AT287932B (de) 1971-02-10
BR6803654D0 (pt) 1973-01-16
FI48098B (fr) 1974-02-28
BE723189A (fr) 1969-04-30
IL30879A (en) 1972-11-28
CH505855A (de) 1971-04-15
IE33567L (en) 1969-05-03
DK131576C (da) 1976-01-05
FI48098C (fi) 1974-06-10
IL30879A0 (en) 1968-12-26
GB1247022A (en) 1971-09-22
ES359842A1 (es) 1970-06-16
DK131576B (da) 1975-08-04
IE33567B1 (en) 1974-08-21
SE352360B (fr) 1972-12-27
AT297236B (de) 1972-03-10

Similar Documents

Publication Publication Date Title
Chen et al. Ant-repellent triterpenoids from Cordia alliodora
Partridge et al. Vitamin D3 Metabolites I. Synthesis of 25‐hydroxycholesterol
NO143887B (no) Innretning for detektering av kroppsutflod, saerlig utidig urinering.
DE2424498A1 (de) Verfahren zur herstellung von 25hydroxycholesterin
US3966777A (en) Process for the production of 1α-hydroxy provitamin D3 and 1α-hydroxy vitamin D3
NO140978B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
US3247189A (en) 3, 19 and 20 oxygenated-delta5-pregnenes
DK171850B1 (da) Fremgangsmåde til fremstilling af 17alfa-ethynyl-17beta-hydroxy-18-methyl-4,15-østradien-3-on og mellemprodukter til anvendelse ved fremgangsmåden
US3773758A (en) 7alpha-cyano-17-hydroxy-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid ypsilon-lactone and related compounds
US3433813A (en) 1-adamantyl and 1-adamantylmethyl carbonates of testosterone and selected derivatives
US2760966A (en) Compounds for synthesizing steroids
US3507889A (en) Process for the preparation of 17alpha-dihydroequilenin and related compounds
Popper et al. Antiandrogenic and progestational activity of some 17-oxygenated 15-dehydro steroids
US3284505A (en) 19-nor-b-nortestosterones
CH577446A5 (en) Anabolic progestational anti-androgenic 9-beta 10-alpha
US4145357A (en) Steroid derivatives and process for preparing the same
Kutney et al. AZA STEROIDS: II. SYNTHESIS OF 6-AZA STEROIDS—A NOVEL CLASS OF AZAANDROSTANE ANALOGUES
US3155684A (en) Optionally 17alpha-alkylated 17belta-(substituted-oxy)-2-oxa-5alpha-androstan-3-ones
US3178408A (en) Aminosteroid compounds and process for their manufacture
US3450720A (en) 3-difluoromethylene steroids
US3145200A (en) Steroido[3.2-c]isoxazoles and preparation thereof
IL32699A (en) 6-substituted-13-polycarbonalkyl-18,19 dinorpregn-4-en-3-ones,their preparation and pharmaceutical compositions containing them
CH695422A5 (de) Verfahren zur Einführung einer 1,2-Doppelbindung bei 3-Oxo-4-azasteroidverbindungen.
NO123549B (fr)
US3128282A (en) 11-oxygenated 17alpha, 21-dihydroxy-3-oxa-a-homopregn-4a-ene-4,20-diones, esters thereof, and intermediate thereto